Cargando…

A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables

BACKGROUND: Currently, a surgical approach is the best curative treatment for those with hepatocellular carcinoma (HCC). However, this requires HCC detection and removal of the lesion at an early stage. Unfortunately, most cases of HCC are detected at an advanced stage because of the lack of accurat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mengjun, Mehta, Anand, Block, Timothy M, Marrero, Jorge, Di Bisceglie, Adrian M, Devarajan, Karthik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980825/
https://www.ncbi.nlm.nih.gov/pubmed/24564861
http://dx.doi.org/10.1186/1755-8794-6-S3-S9
_version_ 1782479589111496704
author Wang, Mengjun
Mehta, Anand
Block, Timothy M
Marrero, Jorge
Di Bisceglie, Adrian M
Devarajan, Karthik
author_facet Wang, Mengjun
Mehta, Anand
Block, Timothy M
Marrero, Jorge
Di Bisceglie, Adrian M
Devarajan, Karthik
author_sort Wang, Mengjun
collection PubMed
description BACKGROUND: Currently, a surgical approach is the best curative treatment for those with hepatocellular carcinoma (HCC). However, this requires HCC detection and removal of the lesion at an early stage. Unfortunately, most cases of HCC are detected at an advanced stage because of the lack of accurate biomarkers that can be used in the surveillance of those at risk. It is believed that biomarkers that could detect HCC early will play an important role in the successful treatment of HCC. METHODS: In this study, we analyzed serum levels of alpha fetoprotein, Golgi protein, fucosylated alpha-1-anti-trypsin, and fucosylated kininogen from 113 patients with cirrhosis and 164 serum samples from patients with cirrhosis plus HCC. We utilized two different methods, namely, stepwise penalized logistic regression (stepPLR) and model-based classification and regression trees (mob), along with the inclusion of clinical and demographic factors such as age and gender, to determine if these improved algorithms could be used to increase the detection of cancer. RESULTS AND DISCUSSION: The performance of multiple biomarkers was found to be better than that of individual biomarkers. Using several statistical methods, we were able to detect HCC in the background of cirrhosis with an area under the receiver operating characteristic curve of at least 0.95. stepPLR and mob demonstrated better predictive performance relative to logistic regression (LR), penalized LR and classification and regression trees (CART) used in our prior study based on three-fold cross-validation and leave one out cross-validation. In addition, mob provided unparalleled intuitive interpretation of results and potential cut-points for biomarker levels. The inclusion of age and gender improved the overall performance of both methods among all models considered, while the stratified male-only subset provided the best overall performance among all methods and models considered. CONCLUSIONS: In addition to multiple biomarkers, the incorporation of age and gender into statistical models significantly improved their predictive performance in the detection of HCC.
format Online
Article
Text
id pubmed-3980825
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39808252014-04-24 A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables Wang, Mengjun Mehta, Anand Block, Timothy M Marrero, Jorge Di Bisceglie, Adrian M Devarajan, Karthik BMC Med Genomics Research BACKGROUND: Currently, a surgical approach is the best curative treatment for those with hepatocellular carcinoma (HCC). However, this requires HCC detection and removal of the lesion at an early stage. Unfortunately, most cases of HCC are detected at an advanced stage because of the lack of accurate biomarkers that can be used in the surveillance of those at risk. It is believed that biomarkers that could detect HCC early will play an important role in the successful treatment of HCC. METHODS: In this study, we analyzed serum levels of alpha fetoprotein, Golgi protein, fucosylated alpha-1-anti-trypsin, and fucosylated kininogen from 113 patients with cirrhosis and 164 serum samples from patients with cirrhosis plus HCC. We utilized two different methods, namely, stepwise penalized logistic regression (stepPLR) and model-based classification and regression trees (mob), along with the inclusion of clinical and demographic factors such as age and gender, to determine if these improved algorithms could be used to increase the detection of cancer. RESULTS AND DISCUSSION: The performance of multiple biomarkers was found to be better than that of individual biomarkers. Using several statistical methods, we were able to detect HCC in the background of cirrhosis with an area under the receiver operating characteristic curve of at least 0.95. stepPLR and mob demonstrated better predictive performance relative to logistic regression (LR), penalized LR and classification and regression trees (CART) used in our prior study based on three-fold cross-validation and leave one out cross-validation. In addition, mob provided unparalleled intuitive interpretation of results and potential cut-points for biomarker levels. The inclusion of age and gender improved the overall performance of both methods among all models considered, while the stratified male-only subset provided the best overall performance among all methods and models considered. CONCLUSIONS: In addition to multiple biomarkers, the incorporation of age and gender into statistical models significantly improved their predictive performance in the detection of HCC. BioMed Central 2013-11-11 /pmc/articles/PMC3980825/ /pubmed/24564861 http://dx.doi.org/10.1186/1755-8794-6-S3-S9 Text en Copyright © 2013 Wang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Wang, Mengjun
Mehta, Anand
Block, Timothy M
Marrero, Jorge
Di Bisceglie, Adrian M
Devarajan, Karthik
A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables
title A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables
title_full A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables
title_fullStr A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables
title_full_unstemmed A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables
title_short A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables
title_sort comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980825/
https://www.ncbi.nlm.nih.gov/pubmed/24564861
http://dx.doi.org/10.1186/1755-8794-6-S3-S9
work_keys_str_mv AT wangmengjun acomparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables
AT mehtaanand acomparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables
AT blocktimothym acomparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables
AT marrerojorge acomparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables
AT dibisceglieadrianm acomparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables
AT devarajankarthik acomparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables
AT wangmengjun comparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables
AT mehtaanand comparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables
AT blocktimothym comparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables
AT marrerojorge comparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables
AT dibisceglieadrianm comparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables
AT devarajankarthik comparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables